-
Our Research Strategy
… in the presence of PD-implicated genetic mutations, environmental contributors, aging and other factors sets the stage … investigations of Parkinson's biology. The power of health tech (such as smartphones, wearable devices and data … Foundation partners with biotechnology, pharmaceutical and health tech companies to advance our shared goals. Review …
-
Biomarker and DNA Samples Collection Add-on Study to the Phase III Trial of Isradipine
… STEADY-PD III study, funded by the National Institutes of Health (NIH), seeks to illustrate that isradipine is helpful …
-
Blood Proteins for the Treatment of Parkinson’s Disease
… & Design: Components of blood have been found to improve health and enhance multiple biological functions in …
-
Development of Nanobodies as Novel Tools to Characterize LRRK2 as a Potential Drug Target for Parkinson's Disease
… information regarding the role of LRRK2 in neurons in health and disease. …
-
Novel LRRK2 Antisense Oligonucleotides as a Therapy for Parkinson's Disease
… activity has been linked to altered mitochondrial health (powerhouse of the cell), axon outgrowth (cell …
-
Michael J. Fox: 'Each step is a new adventure'
May 1, 2019
… recently told The New York Times , 2018 brought new health issues that posed arguably the greatest challenges he …